|
End-of-day quote
Shanghai S.E.
2026-10-30
|
5-day change | 1st Jan Change | ||
| 36.11 CNY | +1.12% |
|
-0.06% | -15.14% |
| Market Cap | 11.49B 1.73B 1.55B 1.42B 1.29B 2.41B 164B 2.45B 16.97B 6.81B 86.26B 6.48B 6.34B 272B | P/E 2024 |
11.3x | P/E 2025 | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 8.89B 1.34B 1.2B 1.1B 997M 1.86B 127B 1.9B 13.12B 5.26B 66.68B 5.01B 4.9B 210B | EV / Sales 2024 |
3.4x | EV / Sales 2025 | 3.72x |
| Free-Float |
39.36% | Yield 2024 |
5.3% | Yield 2025 | 4.13% |
| 1 day | +1.12% | ||
| 1 week | -0.06% | ||
| Current month | -0.66% | ||
| 1 month | -0.66% | ||
| 3 months | -6.91% | ||
| 6 months | -10.75% | ||
| Current year | -15.14% |
| 1 week | 35.53 |  | 36.94 |
| 1 month | 34.85 | | 37.12 |
| Current year | 34.8 | | 46 |
| 1 year | 34.8 | | 48.99 |
| 3 years | 26.95 | | 57.98 |
| 5 years | 22.73 | | 57.98 |
| 10 years | 13.54 | | 140.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yuan Dong Guo
CEO | Chief Executive Officer | 56 | 2014-11-19 |
Jun Chen
DFI | Director of Finance/CFO | 48 | 2019-10-24 |
Li Li Wen
IRC | Investor Relations Contact | 46 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Da Bin Chen
CHM | Chairman | 70 | 2015-01-07 |
Yu Cheng Zhou
BRD | Director/Board Member | 44 | 2015-01-07 |
Yuan Dong Guo
BRD | Director/Board Member | 56 | 2015-01-07 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.12% | -0.06% | -19.95% | -6.36% | 1.71B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,224B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 662B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 249B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 205B | |
| Average | +1.67% | +4.91% | +39.93% | +74.19% | 417.86B | |
| Weighted average by Cap. | +1.17% | +6.34% | +50.88% | +98.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.81B 422M 378M 347M 315M 588M 40.04B 599M 4.14B 1.66B 21.06B 1.58B 1.55B 66.42B | 2.98B 448M 401M 369M 334M 625M 42.53B 637M 4.4B 1.77B 22.37B 1.68B 1.65B 70.56B |
| Net income | 1.05B 158M 141M 130M 118M 220M 15B 225M 1.55B 623M 7.89B 593M 580M 24.88B | 938M 141M 126M 116M 105M 197M 13.38B 200M 1.38B 556M 7.04B 529M 518M 22.2B |
| Net Debt | -2.35B -353M -316M -291M -264M -493M -33.55B -502M -3.47B -1.39B -17.65B -1.33B -1.3B -55.65B | -2.61B -392M -351M -323M -293M -547M -37.22B -557M -3.85B -1.55B -19.58B -1.47B -1.44B -61.74B |
Employees
671
Sector
Pharmaceuticals
Calendar
09:30pm
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-30 | CN¥36.11 | +1.12% | 2,524,416 |
| 26-10-29 | CN¥35.71 | -0.78% | 1,910,570 |
| 26-10-28 | CN¥35.99 | +0.03% | 1,725,100 |
| 26-10-27 | CN¥35.98 | -1.69% | 1,621,330 |
| 26-10-26 | CN¥36.60 | +1.30% | 2,453,350 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600211 Stock
Select your edition
All financial news and data tailored to specific country editions
